Volume 8, Issue 6, 1 September 2019

Optimal antithrombotic therapy and vascular access site in the management of acute coronary syndromes

• Extract
• View article

Outcomes of medically managed patients with myocardial infarction

• Abstract
• View article

Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction

• Abstract
• View article

Sex-related response to bivalirudin and unfractionated heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A subgroup analysis of the VALIDATE-SWEDEHEART trial

• Abstract
• View article
• Supplementary data

Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART

• Abstract
• View article

Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes

• Abstract
• View article

The use of antiplatelet agents after an acute coronary syndrome in a large community Italian setting of more than 12 million subjects

• Abstract
• View article
• Supplementary data

Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI

• Abstract
• View article
• Supplementary data

Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y₁₂ receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery

• Abstract
• View article

The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials

• Abstract
• View article
• Supplementary data

Current perspectives on location of monitoring and length of stay following PPCI for ST elevation myocardial infarction

• Abstract
• View article